08:02 AM EDT, 09/10/2025 (MT Newswires) -- Waldencast ( WALD ) said Wednesday that the US Food and Drug Administration has approved its Obagi saypha MagIQ, an injectable hyaluronic acid gel.

The company said it will launch the product in the US next year.

Waldencast ( WALD ) said a pivotal trial of 270 patients over 48 weeks met primary and key secondary endpoints in measuring the change in the nasolabial fold, also known as the "smile line," the crease that extends from the sides of the nose to the corners of the mouth.

Waldencast ( WALD ) shares were 0.5% higher in premarket trading.